MARLBOROUGH, Mass. / Sep 30, 2025 / Business Wire / Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) will mark the start of Breast Cancer Awareness Month by ringing the Nasdaq opening bell for the 19th year. The company will also continue its comprehensive #BustTheMyth patient education campaign following new survey data that shows nearly half of women who are recommended a mammogram either skip or delay the exam.
“For 40 years, Hologic has been dedicated to developing and advancing innovative technologies, including those that detect and treat breast cancer,” said Steve MacMillan, Chairman, President and Chief Executive Officer at Hologic. “However, our technologies can only make a difference if women are screened and unfortunately, there are still far too many women who are missing their annual mammogram. During Breast Cancer Awareness Month, it is incumbent upon all of us to spread the word about the importance of early detection.”
Breast cancer is the most common cancer diagnosed among women in the U.S. Behind lung cancer, it is the second leading cause of death from cancer among women.1 The disease has a 99% survival rate when caught early,2 and mammography remains the gold standard for early detection. However, based on a recent Harris Poll survey3 of over 1,100 women in the U.S., 48% of women who were recommended mammograms say they have skipped or delayed the exam.
Other alarming takeaways show that common myths around breast cancer and screening persist:
Through traditional and social media, informational emails, educational materials and posters provided to doctors’ offices and other approaches, Hologic’s #BustTheMyth campaign uses relatable messaging and shows real women from all over the world to help debunk common misconceptions about breast cancer and screening.
“Breast Cancer Awareness Month is a powerful reminder of the importance of early detection of a disease that has such a high survival rate when caught early,” said Mark Horvath, President of Breast & Skeletal Health Solutions at Hologic. “We hope that the Bust the Myth campaign will continue to help break down barriers around screening, educate patients about breast density and help more women receive potentially lifesaving care.”
The company also released a new video that takes women step-by-step through what happens during a mammogram, helping to demystify the procedure for women who don’t know what to expect. Join the conversation and help spread the word using #BustTheMyth on social media and visiting Hologic.com/BustTheMyth.
Hologic will also sponsor breast cancer awareness walks across the U.S., including Making Strides Against Breast Cancer in Boston, Massachusetts and Wilmington, Delaware; and the Susan G. Komen More Than Pink Walk in San Diego, California.
About Hologic, Inc.
Hologic, Inc. is a global leader in women’s health dedicated to developing innovative medical technologies that effectively detect, diagnose and treat health conditions and raise the standard of care around the world. To learn more, visit www.hologic.com and connect with us on LinkedIn, Facebook, X, Instagram and YouTube.
References
1 American Cancer Society. Breast cancer facts & figures. Cancer.org. Published 2024. https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html
2. Survival rates for breast cancer. American Cancer Society. (n.d.) https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html
3 This survey was conducted online within the United States by The Harris Poll on behalf of Hologic from May 20-22, 2025, among 1,123 women ages 18+. The sampling precision of Harris online polls is measured by using a Bayesian credible interval. For this study, the sample data is accurate to within +/- 3.5 percentage points using a 95% confidence level. This credible interval will be wider among subsets of the surveyed population of interest. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.
4 Dense Breasts. www.breastcancer.org. https://www.breastcancer.org/risk/risk-factors/dense-breasts
5 CDC. Breast Cancer In Young Women. Bring Your Brave Campaign. Published March 28, 2024. https://www.cdc.gov/bring-your-brave/breast-cancer-in-young-women/index.html
6 Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Breast cancer in adolescents and young adults. Pediatric Blood & Cancer. 2018;65(12):e27397. doi:https://doi.org/10.1002/pbc.27397

| Last Trade: | US$74.88 |
| Daily Change: | 0.12 0.16 |
| Daily Volume: | 2,620,752 |
| Market Cap: | US$16.690B |
November 25, 2025 November 03, 2025 October 21, 2025 October 02, 2025 | |

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load